The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Caredx Inc’s stock clocked out at $17.05, down -3.89% from its previous closing price of $17.74. In other words, the price has decreased by -$3.89 from its previous closing price. On the day, 1.13 million shares were traded.
Ratios:
To gain a deeper understanding of CDNA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.11. For the most recent quarter (mrq), Quick Ratio is recorded 3.84 and its Current Ratio is at 4.11. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when COURNOYER CHRISTINE sold 29,136 shares for $15.96 per share. The transaction valued at 465,022 led to the insider holds 37,045 shares of the business.
COURNOYER CHRISTINE bought 29,136 shares of CDNA for $465,021 on May 12 ’25. On May 12 ’25, another insider, Christine M. Cournoyer, who serves as the Director of the company, bought 12,000 shares for $15.36 each.
Valuation Measures:
As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.80, and their Forward P/E ratio for the next fiscal year is 103.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.74 while its Price-to-Book (P/B) ratio in mrq is 2.49.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $12.90. The 50-Day Moving Average of the stock is -3.10%, while the 200-Day Moving Average is calculated to be -26.43%.
Shares Statistics:
A total of 55.46M shares are outstanding, with a floating share count of 51.86M. Insiders hold about 6.87% of the company’s shares, while institutions hold 105.74% stake in the company.
